Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Human Papillomavirus | Research

Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community

Authors: Michael Egbon, Tolulope Ojo, Aminu Aliyu, Zainab Shinkafi Bagudu

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Over 80% of new cervical cancer cases occur in women living in low- and middle-income countries. It is the second highest cause of female cancer deaths in Nigeria. School based vaccination programs are an effective strategy for delivering the HPV vaccine to adolescent girls. This study aims to understand the challenges to implementing school-based HPV vaccination programs, particularly in a remote rural setting where vaccine hesitancy is high.

Methods

A 22- item interviewer administered questionnaire was used to evaluate HPV knowledge and willingness to get the HPV vaccinate among 100 female secondary school students as part of an HPV vaccination pilot in a rural community in Kebbi State, Nigeria. Additionally, semi-structured interviews were used to assess community knowledge and attitudes on cervical cancer and HPV vaccination. Data collected were analyzed thematically to understand challenges and generate lessons for vaccine delivery in the study setting.

Results

Knowledge of HPV and cervical cancer among junior secondary school aged girls was fair with a mean score of 66.05%. For senior secondary school aged girls, the knowledge score ranged from 70 to 100% with a mean of 96.25% indicating good knowledge of HPV and cervical cancer. All participants (n = 100) received the first vaccine dose but due to COVID-19, 33 participants were not able to complete the vaccine dosage within the recommended 6-month schedule. Of the parents who provided consent, none could afford the vaccine out of pocket. Challenges to vaccine delivery included operational costs exacerbated by lack of adequate health workforce and infrastructure in the study setting.

Conclusion

An exploration of sociocultural perspectives and contextual realities is crucial to understanding the complexities of HPV vaccine introduction from the perspective of the target audience, and the local community. Strategies for introducing the HPV vaccine should address community concerns through effective communication, appropriate delivery, and targeted advocacy to make the vaccination program locally relevant. While school-based HPV immunization programs have been shown to be successful, adequate design, planning and monitoring is important. Additionally, considerations must be made to account for the high operational cost of vaccine delivery in rural, hard to reach areas where human resources and infrastructure are limited.
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMed
3.
go back to reference Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:F1–31.CrossRef Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:F1–31.CrossRef
5.
go back to reference Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, et al. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016. Papillomavirus Res. 2017;4:72–8.CrossRef Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, et al. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016. Papillomavirus Res. 2017;4:72–8.CrossRef
8.
go back to reference Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32, Part A):4761–7.CrossRef Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32, Part A):4761–7.CrossRef
10.
go back to reference Howard N, Gallagher KE, Mounier-Jack S, Burchett HED, Kabakama S, LaMontagne DS, et al. What works for human papillomavirus vaccine introduction in low and middle-income countries? Papillomavirus Res. 2017;4:22–5.CrossRef Howard N, Gallagher KE, Mounier-Jack S, Burchett HED, Kabakama S, LaMontagne DS, et al. What works for human papillomavirus vaccine introduction in low and middle-income countries? Papillomavirus Res. 2017;4:22–5.CrossRef
14.
go back to reference Ozawa S, Wonodi C, Babalola O, Ismail T, Bridges J. Using best-worst scaling to rank factors affecting vaccination demand in northern Nigeria. Vaccine. 2017;35(47):6429–37.CrossRef Ozawa S, Wonodi C, Babalola O, Ismail T, Bridges J. Using best-worst scaling to rank factors affecting vaccination demand in northern Nigeria. Vaccine. 2017;35(47):6429–37.CrossRef
15.
go back to reference Babalola S, Lawan U. Factors predicting BCG immunization status in northern Nigeria: a behavioral-ecological perspective. J Child Health Care. 2009;13(1):46–62.CrossRef Babalola S, Lawan U. Factors predicting BCG immunization status in northern Nigeria: a behavioral-ecological perspective. J Child Health Care. 2009;13(1):46–62.CrossRef
16.
go back to reference Odeigah L, Rasaki SO, Ajibola AF, Hafsat AA, Sule AG, Musah Y. High risk sexual behavior among adolescent senior secondary school students in Nigeria. Afr Health Sci. 2019;19(1):1467–77.CrossRef Odeigah L, Rasaki SO, Ajibola AF, Hafsat AA, Sule AG, Musah Y. High risk sexual behavior among adolescent senior secondary school students in Nigeria. Afr Health Sci. 2019;19(1):1467–77.CrossRef
17.
go back to reference Wilson R. HPV vaccine acceptance in West Africa: a systematic literature review. Vaccine. 2021;39(37):5277–84.CrossRef Wilson R. HPV vaccine acceptance in West Africa: a systematic literature review. Vaccine. 2021;39(37):5277–84.CrossRef
19.
go back to reference Fagbule OF, Kanmodi KK, Aliemeke EO, Ogunniyi KE, Ogbeide M, Victor SO, et al. Knowledge of HPV and HPV vaccine among senior secondary school students in Nigeria: implications on cancer prevention strategies, the CHANCE study. Popul Med. 2020;2:1–10.CrossRef Fagbule OF, Kanmodi KK, Aliemeke EO, Ogunniyi KE, Ogbeide M, Victor SO, et al. Knowledge of HPV and HPV vaccine among senior secondary school students in Nigeria: implications on cancer prevention strategies, the CHANCE study. Popul Med. 2020;2:1–10.CrossRef
20.
go back to reference Morhason-Bello IO, Wallis S, Adedokun BO, Adewole IF. Willingness of reproductive-aged women in a Nigerian community to accept human papillomavirus vaccination for their children. J Obstet Gynaecol Res. 2015;41(10):1621–9.CrossRef Morhason-Bello IO, Wallis S, Adedokun BO, Adewole IF. Willingness of reproductive-aged women in a Nigerian community to accept human papillomavirus vaccination for their children. J Obstet Gynaecol Res. 2015;41(10):1621–9.CrossRef
21.
go back to reference Ratanasiripong NT, Cheng AL, Enriquez M. What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine. Vaccine. 2013;31(10):1370–6.CrossRef Ratanasiripong NT, Cheng AL, Enriquez M. What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine. Vaccine. 2013;31(10):1370–6.CrossRef
22.
go back to reference Rabiu KA, Alausa TG, Akinlusi FM, Davies NO, Shittu KA, Akinola OI. Parental acceptance of human papillomavirus vaccination for adolescent girls in Lagos, Nigeria. J Family Med Prim Care. 2020;9(6):2950–7.CrossRef Rabiu KA, Alausa TG, Akinlusi FM, Davies NO, Shittu KA, Akinola OI. Parental acceptance of human papillomavirus vaccination for adolescent girls in Lagos, Nigeria. J Family Med Prim Care. 2020;9(6):2950–7.CrossRef
23.
go back to reference Balogun F, Omotade O. “She must have been sleeping around”…: contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria. PLoS One. 2018;13(9):e0203950.CrossRef Balogun F, Omotade O. “She must have been sleeping around”…: contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria. PLoS One. 2018;13(9):e0203950.CrossRef
24.
go back to reference Rashid S, Labani S, Das BC. Knowledge, awareness and attitude on HPV, HPV vaccine and cervical Cancer among the college students in India. PLoS One. 2016;11(11):e0166713.CrossRef Rashid S, Labani S, Das BC. Knowledge, awareness and attitude on HPV, HPV vaccine and cervical Cancer among the college students in India. PLoS One. 2016;11(11):e0166713.CrossRef
25.
go back to reference Santos AC, Silva NNT, Carneiro CM, Coura-Vital W, Lima AA. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians. BMC Public Health. 2020;20(1):301.CrossRef Santos AC, Silva NNT, Carneiro CM, Coura-Vital W, Lima AA. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians. BMC Public Health. 2020;20(1):301.CrossRef
26.
go back to reference Turiho AK, Okello ES, Muhwezi WW, Harvey S, Byakika-Kibwika P, Meya D, et al. Effect of school-based human papillomavirus (HPV) vaccination on adolescent girls’ knowledge and acceptability of the HPV vaccine in Ibanda District in Uganda. Afr J Reprod Health. 2014;18(4):45–53.PubMedPubMedCentral Turiho AK, Okello ES, Muhwezi WW, Harvey S, Byakika-Kibwika P, Meya D, et al. Effect of school-based human papillomavirus (HPV) vaccination on adolescent girls’ knowledge and acceptability of the HPV vaccine in Ibanda District in Uganda. Afr J Reprod Health. 2014;18(4):45–53.PubMedPubMedCentral
27.
go back to reference PATH, Child Health and Development Centre (CHDC), and the Uganda National Expanded Program on Immunization (UNEPI). HPV Vaccination in Africa: Lessons Learned from a Pilot Program in Uganda. Seattle: PATH; 2011. p. 28. PATH, Child Health and Development Centre (CHDC), and the Uganda National Expanded Program on Immunization (UNEPI). HPV Vaccination in Africa: Lessons Learned from a Pilot Program in Uganda. Seattle: PATH; 2011. p. 28.
28.
go back to reference Preiss S, Garçon N, Cunningham AL, Strugnell R, Friedland LR. Vaccine provision: delivering sustained & widespread use. Vaccine. 2016;34(52):6665–71.CrossRef Preiss S, Garçon N, Cunningham AL, Strugnell R, Friedland LR. Vaccine provision: delivering sustained & widespread use. Vaccine. 2016;34(52):6665–71.CrossRef
29.
go back to reference Bingham A, Drake JK, LaMontagne DS. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med. 2009;163(5):455–61.CrossRef Bingham A, Drake JK, LaMontagne DS. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med. 2009;163(5):455–61.CrossRef
30.
go back to reference Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health. 2012;12(1):370.CrossRef Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health. 2012;12(1):370.CrossRef
31.
go back to reference Masika MM, Ogembo JG, Chabeda SV, Wamai RG, Mugo N. Knowledge on HPV vaccine and cervical Cancer facilitates vaccine acceptability among school teachers in Kitui County, Kenya. PLoS One. 2015;10(8):e0135563.CrossRef Masika MM, Ogembo JG, Chabeda SV, Wamai RG, Mugo N. Knowledge on HPV vaccine and cervical Cancer facilitates vaccine acceptability among school teachers in Kitui County, Kenya. PLoS One. 2015;10(8):e0135563.CrossRef
32.
go back to reference Shinkafi-Bagudu Z. Global partnerships for HPV vaccine must look beyond National Income. JCO Glob Oncol. 2020;6:1746–8.CrossRef Shinkafi-Bagudu Z. Global partnerships for HPV vaccine must look beyond National Income. JCO Glob Oncol. 2020;6:1746–8.CrossRef
33.
go back to reference Umeh IB, Nduka SO, Ekwunife OI. Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study. Cost Eff Resour Alloc. 2016;14(1):8.CrossRef Umeh IB, Nduka SO, Ekwunife OI. Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study. Cost Eff Resour Alloc. 2016;14(1):8.CrossRef
35.
go back to reference Dany M, Chidiac A, Nassar AH. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country. Vaccine. 2015;33(8):1001–7.CrossRef Dany M, Chidiac A, Nassar AH. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country. Vaccine. 2015;33(8):1001–7.CrossRef
36.
go back to reference Ekwunife OI, Lhachimi SK. Cost-effectiveness of human papilloma virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage. BMC Health Serv Res. 2017;17:815.CrossRef Ekwunife OI, Lhachimi SK. Cost-effectiveness of human papilloma virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage. BMC Health Serv Res. 2017;17:815.CrossRef
37.
go back to reference Adeloye D, David RA, Olaogun AA, Auta A, Adesokan A, Gadanya M, et al. Health workforce and governance: the crisis in Nigeria. Hum Resour Health. 2017;15(1):32.CrossRef Adeloye D, David RA, Olaogun AA, Auta A, Adesokan A, Gadanya M, et al. Health workforce and governance: the crisis in Nigeria. Hum Resour Health. 2017;15(1):32.CrossRef
39.
go back to reference Sarley D, Mahmud M, Idris J, Osunkiyesi M, Dibosa-Osadolor O, Okebukola P, et al. Transforming vaccines supply chains in Nigeria. Vaccine. 2017;35(17):2167–74.CrossRef Sarley D, Mahmud M, Idris J, Osunkiyesi M, Dibosa-Osadolor O, Okebukola P, et al. Transforming vaccines supply chains in Nigeria. Vaccine. 2017;35(17):2167–74.CrossRef
40.
go back to reference Kew O. Reaching the last one per cent: progress and challenges in global polio eradication. Curr Opin Virol. 2012;2(2):188–98.CrossRef Kew O. Reaching the last one per cent: progress and challenges in global polio eradication. Curr Opin Virol. 2012;2(2):188–98.CrossRef
42.
go back to reference Bonner K, Banura C, Basta NE. HPV vaccination strategies targeting hard-to-reach populations: out-of-school girls in LMICs. Vaccine. 2018;36(2):191–3.CrossRef Bonner K, Banura C, Basta NE. HPV vaccination strategies targeting hard-to-reach populations: out-of-school girls in LMICs. Vaccine. 2018;36(2):191–3.CrossRef
43.
go back to reference Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, et al. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis. 2012;206(5):678–86.CrossRef Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, et al. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis. 2012;206(5):678–86.CrossRef
Metadata
Title
Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community
Authors
Michael Egbon
Tolulope Ojo
Aminu Aliyu
Zainab Shinkafi Bagudu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-13975-3

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue